AECC Excellence Program: PreMetaCan, Precision Metabolism

#CICbioGUNE has been selected to receive €2 million from the Spanish Association Against Cancer (AECC) for its PreMetaCan project, which focuses on the study of metabolism in cancer and the optimization of personalized therapies.

This award strengthens the position of #CICbioGUNE as a multidisciplinary scientific center of excellence, combining fundamental with applied research methodologies, with the goal of developing more effective treatments based on precision medicine.

In addition, several young investigators at the center have been recognized with distinctions and grants in various categories, consolidating #CICbioGUNE's track record in translational research and its contribution to the fight against cancer.

#CICbioGUNE, member of BRTA, has been selected in the Excellence Program Grants from the @contraelcancer (AECC) receiving €2 million for the development of the PreMetaCan project: Precision Metabolism for Next-Generation Cancer Management. This recognition, awarded during the IV Research Grant Ceremony on Cancer, reinforces #CICbioGUNE’s position as a leading center in multidisciplinary biomedical research.

PreMetaCan, with Arkaitz Carracedo as leader of the program and Jesús Jiménez-Barbero, as program director, aims to unravel how metabolism influences cancer development and resistance, optimizing combination therapies and maximizing the effectiveness of precision medicine. To achieve this, it will rely on advanced technologies such as nuclear magnetic resonance (NMR), with scientific focus on the development of groundbreaking initiatives in metabolomics, glycomics, and translational oncology. This comprehensive and synergic approach will allow for the development of treatments better tailored to the metabolic characteristics of each patient, improving both diagnosis and therapeutic efficacy.

#CICbioGUNE's Director, Prof. José M. Mato, emphasized that this funding is a recognition of two decades of effort in generating basic knowledge with social impact. He highlighted how the center has turned challenges into strengths, consolidating a scientific trajectory that now opens new opportunities for young leadership and multidisciplinary work. With projects like PreMetaCan, #CICbioGUNE aims to establish itself as an international reference in the study of metabolism related to cancer.

Although #CICbioGUNE does not exclusively focus on cancer research, it has developed a strong line of work in oncology, supported by its expertise in metabolism, metabolomics, and glycomics. This recognition strengthens its position at the forefront of cancer research, backed by the AECC’s Scientific Foundation Centers Accreditation, and aligns with the AECC’s vision to promote translational projects that integrate basic excellent research with clinical applications.

With these grants, amounting to over three million euros and distributed across 12 awards, the AECC reaffirms its commitment to fostering high-quality patient-centered research, promoting scientific culture, and supporting new generations of researchers.

#bioGUNE_EmpoweringWomen #health #youtubehealth